Adenovirus-mediated Transfer of SiRNA Against Basic Fibroblast Growth Factor MRNA Enhances the Sensitivity of Glioblastoma Cells to Chemotherapy

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2010 Mar 12

PMID 20221717

Citations 4

Authors

Xuequan Feng

Biao Zhang

Jinhuan Wang

Xinnv Xu

Na Lin

Hongsheng Liu

Affiliations

Soon will be listed here.

Abstract

Basic fibroblast growth factor (bFGF) is an important growth factor for glioma cell proliferation and invasion. BFGF is overexpressed in malignant gliomas and its level is associated with malignant grades and clinical outcome of patients with gliomas. Small interfering RNAs (siRNA) are synthetic forms of microRNA made of short double stranded RNA, and they effectively catalyze the degradation of their target mRNA. The use of siRNA has become a key method in the suppression of gene expression and the development of therapeutic agents. In this study, we used an adenovirus(Ad)-mediated transfer of siRNA against bFGF mRNA (Ad-bFGF-siRNA) to study the effect of down-regulating bFGF expression on the sensitivity of glioma cells to chemotherapeutics. An optimal siRNA sequence specific for bFGF mRNA was cloned into an adenoviral vector and transfected into three glioma cell lines: U251, A172, and LN229. Methyl thiazolyl tetrazolium (MTT) assays were used to examine changes in cell proliferation, and changes in bFGF mRNA and protein levels in U251 cells were detected using quantitative RT-PCR and Western blot, respectively. Apoptosis of U251 cells was detected using Hoechst staining and flow cytometry, with expression of apoptosis-related proteins evaluated by Western blot. Following the transfection of a bFGF-specific siRNA, mRNA and protein levels of bFGF decreased significantly. Lower rates of proliferation and increased levels of apoptosis also were associated with the Ad-bFGF-siRNA-transfected group compared to control group. Decreased expression of Bcl-2, Bcl-xL, Jak-1, and STAT-3 and increased expression of Bax also were detected in the Ad-bFGF-siRNA-transfected group. For cells treated with both Ad-bFGF-siRNA and chemotherapeutics, a significant reduction in cell survival was observed compared to treatment with Ad-bFGF-siRNA or chemotherapeutics alone. Overall, we found that targeting bFGF mRNA with a siRNA resulted in lower rates of proliferation, increased apoptosis, and enhanced sensitivity of glioma cells to chemotherapy drugs. This suggests that specific targeting of bFGF mRNA may provide a novel approach for the treatment of glioblastoma multiforme (GBM).

Citing Articles

DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas.

Schramm K, Iskar M, Statz B, Jager N, Haag D, Slabicki M Neuro Oncol. 2019; 21(7):867-877.

PMID: 30943283 PMC: 6620639. DOI: 10.1093/neuonc/noz057.

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.

Peng Y, Huang J, Xiao H, Wu T, Shuai X Int J Nanomedicine. 2018; 13:3467-3480.

PMID: 29942129 PMC: 6007389. DOI: 10.2147/IJN.S164611.

Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.

Wu J, Feng X, Zhang B, Li J, Xu X, Liu J J Neurooncol. 2014; 120(1):33-41.

PMID: 25048528 DOI: 10.1007/s11060-014-1529-8.

MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective?.

Hummel R, Maurer J, Haier J Mol Neurobiol. 2011; 44(3):223-34.

PMID: 21739238 DOI: 10.1007/s12035-011-8197-x.

References

Noda S, Yoshimura S, Sawada M, Naganawa T, Iwama T, Nakashima S . Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells. J Neurooncol. 2001; 52(1):11-21. DOI: 10.1023/a:1010624823158. View

Stegh A, Kim H, Bachoo R, Forloney K, Zhang J, Schulze H . Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev. 2007; 21(1):98-111. PMC: 1759904. DOI: 10.1101/gad.1480007. View

Zeng Z, Yellaturu C, Neeli I, Rao G . 5(S)-hydroxyeicosatetraenoic acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and phosphatidylinositol 3-kinase/Akt signaling, leading to induction of expression of basic fibroblast growth factor 2. J Biol Chem. 2002; 277(43):41213-9. DOI: 10.1074/jbc.M204508200. View

Conti L, Govoni S, Battaini F, Cattaneo E . STAT signalling in the mature and aging brain. Int J Dev Neurosci. 2000; 18(4-5):439-46. DOI: 10.1016/s0736-5748(00)00007-1. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Zhao Y, Bai W, Yan Z, Chen G, Liu S, Deng Q . [Construction of an antisense RNA recombinant adenovirus vector of the human PDE5A1 gene promoter]. Zhonghua Nan Ke Xue. 2005; 11(5):331-4. View

Auguste P, Gursel D, Lemiere S, Reimers D, Cuevas P, Carceller F . Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res. 2001; 61(4):1717-26. View

Bian X, Du L, Shi J, Cheng Y, Liu F . Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol. 2000; 22(3):267-74. View

Wen P, Kesari S . Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507. DOI: 10.1056/NEJMra0708126. View

10.

Fukui S, Nawashiro H, Otani N, Ooigawa H, Nomura N, Yano A . Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. Cancer. 2003; 97(12):3061-7. DOI: 10.1002/cncr.11450. View

11.

He L, Kim B, Kim K, Kwon O, Kim S, Bae E . NF-kappaB inhibition enhances caspase-3 degradation of Akt1 and apoptosis in response to camptothecin. Cell Signal. 2007; 19(8):1713-21. DOI: 10.1016/j.cellsig.2007.03.006. View

12.

Takahashi J, Fukumoto M, Kozai Y, Ito N, Oda Y, Kikuchi H . Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett. 1991; 288(1-2):65-71. DOI: 10.1016/0014-5793(91)81004-r. View

13.

Baguma-Nibasheka M, Li A, Murphy P . The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells. Mol Cell Endocrinol. 2007; 267(1-2):127-36. DOI: 10.1016/j.mce.2007.01.008. View

14.

Bikfalvi A, Klein S, Pintucci G, Rifkin D . Biological roles of fibroblast growth factor-2. Endocr Rev. 1997; 18(1):26-45. DOI: 10.1210/edrv.18.1.0292. View

15.

Aoki T, Kato S, Fox J, Okamoto K, Sakata K, Morimatsu M . Inhibition of autocrine fibroblast growth factor signaling by the adenovirus-mediated expression of an antisense transgene or a dominant negative receptor in human glioma cells in vitro. Int J Oncol. 2002; 21(3):629-36. View

16.

Eckenstein F . Fibroblast growth factors in the nervous system. J Neurobiol. 1994; 25(11):1467-80. DOI: 10.1002/neu.480251112. View

17.

Kim H . Assignment1 of the human basic fibroblast growth factor gene FGF2 to chromosome 4 band q26 by radiation hybrid mapping. Cytogenet Cell Genet. 1999; 83(1-2):73. DOI: 10.1159/000015129. View

18.

Shen C, Buck A, Liu X, Winkler M, Reske S . Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 2003; 539(1-3):111-4. DOI: 10.1016/s0014-5793(03)00209-6. View

19.

Wang S, Wang J, Zhang Y, Xu X, Liu H . [Effects of small interfering RNA targeting basic fibroblast growth factor on proliferation and apoptosis of glioma cell line U251]. Ai Zheng. 2008; 27(9):905-9. View

20.

Kim D, Rossi J . RNAi mechanisms and applications. Biotechniques. 2008; 44(5):613-6. PMC: 2727154. DOI: 10.2144/000112792. View